Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Hoke

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The American Journal of Tropical Medicine and Hygiene|August 31, 1999
An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeysB Raengsakulrach, A Nisalak, M Gettayacamin, et al.
Emerging Infectious Diseases|March 21, 1998
Partnerships for detecting emerging infectious diseases: Nepal and global influenza surveillanceJ M Gambel, D R Shlim, L C Canas, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1990
Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humansC H Hoke, F J Malinoski, K H Eckels, et al.
The Journal of Infectious Diseases|May 11, 1992
Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from MexicoJ Ticehurst, L L Rhodes, K Krawczynski, et al.
Vaccine|January 11, 1992
Hepatitis A in the US Army: epidemiology and vaccine developmentC H Hoke, L N Binn, J E Egan, et al.
Vaccine|October 12, 2000
Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humansN Kanesa-thasan, J J Smucny, C H Hoke, et al.
The Journal of Infectious Diseases|June 1, 1984
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiersW H Bancroft, R M Scott, K H Eckels, et al.
The Journal of Infectious Diseases|March 1, 1995
Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine: early immune response, persistence of antibody, and response to a third dose at 1 yearR F DeFraites, B H Feighner, L N Binn, et al.
The American Journal of Tropical Medicine and Hygiene|August 27, 1999
Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: immunogenicity and safety of vaccine administered in two dosing regimensR F Defraites, J M Gambel, C H Hoke, et al.
Vaccine|April 20, 2001
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersN Kanesa-thasan, W Sun, G Kim-Ahn, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The American Journal of Tropical Medicine and Hygiene|August 31, 1999
An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeysB Raengsakulrach, A Nisalak, M Gettayacamin, et al.
Emerging Infectious Diseases|March 21, 1998
Partnerships for detecting emerging infectious diseases: Nepal and global influenza surveillanceJ M Gambel, D R Shlim, L C Canas, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1990
Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humansC H Hoke, F J Malinoski, K H Eckels, et al.
The Journal of Infectious Diseases|May 11, 1992
Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from MexicoJ Ticehurst, L L Rhodes, K Krawczynski, et al.
Vaccine|January 11, 1992
Hepatitis A in the US Army: epidemiology and vaccine developmentC H Hoke, L N Binn, J E Egan, et al.
Vaccine|October 12, 2000
Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humansN Kanesa-thasan, J J Smucny, C H Hoke, et al.
The Journal of Infectious Diseases|June 1, 1984
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiersW H Bancroft, R M Scott, K H Eckels, et al.
The Journal of Infectious Diseases|March 1, 1995
Immunization of US soldiers with a two-dose primary series of inactivated hepatitis A vaccine: early immune response, persistence of antibody, and response to a third dose at 1 yearR F DeFraites, B H Feighner, L N Binn, et al.
The American Journal of Tropical Medicine and Hygiene|August 27, 1999
Japanese encephalitis vaccine (inactivated, BIKEN) in U.S. soldiers: immunogenicity and safety of vaccine administered in two dosing regimensR F Defraites, J M Gambel, C H Hoke, et al.
Vaccine|April 20, 2001
Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteersN Kanesa-thasan, W Sun, G Kim-Ahn, et al.
Pageof 7